Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa.

Vargas A, Kim HS, Baral E, Yu WQ, Craft CM, Lee EJ.

PLoS One. 2017 Aug 2;12(8):e0182389. doi: 10.1371/journal.pone.0182389. eCollection 2017.

2.

Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus.

Kim SS, Song SH, Kim JH, Jeon YK, Kim BH, Kang MC, Chun SW, Hong SH, Chung M, Kim YK, Kim IJ, Kim YB.

Clin Endocrinol (Oxf). 2017 Aug;87(2):156-164. doi: 10.1111/cen.13360. Epub 2017 May 22.

PMID:
28434209
3.

Mining kidney toxicogenomic data by using gene co-expression modules.

AbdulHameed MD, Ippolito DL, Stallings JD, Wallqvist A.

BMC Genomics. 2016 Oct 10;17(1):790.

4.

Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.

Guo J, Guan Q, Liu X, Wang H, Gleave ME, Nguan CY, Du C.

BMC Nephrol. 2016 Sep 20;17(1):133. doi: 10.1186/s12882-016-0348-x.

5.

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye.

Bauskar A, Mack WJ, Mauris J, Argüeso P, Heur M, Nagel BA, Kolar GR, Gleave ME, Nakamura T, Kinoshita S, Moradian-Oldak J, Panjwani N, Pflugfelder SC, Wilson MR, Fini ME, Jeong S.

PLoS One. 2015 Sep 24;10(9):e0138958. doi: 10.1371/journal.pone.0138958. eCollection 2015.

6.

Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.

Genereux JC, Qu S, Zhou M, Ryno LM, Wang S, Shoulders MD, Kaufman RJ, Lasmézas CI, Kelly JW, Wiseman RL.

EMBO J. 2015 Jan 2;34(1):4-19. doi: 10.15252/embj.201488896. Epub 2014 Oct 31.

7.

Cholesterol in brain disease: sometimes determinant and frequently implicated.

Martín MG, Pfrieger F, Dotti CG.

EMBO Rep. 2014 Oct;15(10):1036-52. doi: 10.15252/embr.201439225. Epub 2014 Sep 15. Review.

8.

Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis.

Jung GS, Jeon JH, Jung YA, Choi YK, Kim HS, Kim JG, Park KG, Kim MK, Lee IK.

PLoS One. 2014 Aug 22;9(8):e105635. doi: 10.1371/journal.pone.0105635. eCollection 2014.

9.

Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis.

Sansanwal P, Li L, Sarwal MM.

J Am Soc Nephrol. 2015 Mar;26(3):612-25. doi: 10.1681/ASN.2013060577. Epub 2014 Jul 28.

10.

Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.

Asuni AA, Gray B, Bailey J, Skipp P, Perry VH, O'Connor V.

J Biol Chem. 2014 Feb 14;289(7):4532-45. doi: 10.1074/jbc.M113.502690. Epub 2013 Dec 23.

11.

Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Rouse R, Siwy J, Mullen W, Mischak H, Metzger J, Hanig J.

PLoS One. 2012;7(4):e34606. doi: 10.1371/journal.pone.0034606. Epub 2012 Apr 11.

12.

Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.

Jeong S, Ledee DR, Gordon GM, Itakura T, Patel N, Martin A, Fini ME.

Am J Pathol. 2012 May;180(5):2028-39. doi: 10.1016/j.ajpath.2012.01.025. Epub 2012 Mar 20.

13.

Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes.

Schlatzer D, Maahs DM, Chance MR, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK.

Diabetes Care. 2012 Mar;35(3):549-55. doi: 10.2337/dc11-1491. Epub 2012 Jan 11.

14.

Clusterin attenuates the development of renal fibrosis.

Jung GS, Kim MK, Jung YA, Kim HS, Park IS, Min BH, Lee KU, Kim JG, Park KG, Lee IK.

J Am Soc Nephrol. 2012 Jan;23(1):73-85. doi: 10.1681/ASN.2011010048. Epub 2011 Nov 3. Erratum in: J Am Soc Nephrol. 2012 Jun;23(6):1125.

15.

Proteomic analyses of host and pathogen responses during bovine mastitis.

Boehmer JL.

J Mammary Gland Biol Neoplasia. 2011 Dec;16(4):323-38. doi: 10.1007/s10911-011-9229-x. Epub 2011 Sep 4. Review.

16.

Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.

Ding J, List EO, Bower BD, Kopchick JJ.

Endocrinology. 2011 Oct;152(10):3791-802. doi: 10.1210/en.2011-1217. Epub 2011 Jul 26.

17.

Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Hoofnagle AN, Wu M, Gosmanova AK, Becker JO, Wijsman EM, Brunzell JD, Kahn SE, Knopp RH, Lyons TJ, Heinecke JW.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2528-34. doi: 10.1161/ATVBAHA.110.212894. Epub 2010 Sep 16.

18.

Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.

Wyatt AR, Wilson MR.

J Biol Chem. 2010 Feb 5;285(6):3532-9. doi: 10.1074/jbc.M109.079566. Epub 2009 Dec 7.

19.

Structural characterization of clusterin-chaperone client protein complexes.

Wyatt AR, Yerbury JJ, Wilson MR.

J Biol Chem. 2009 Aug 14;284(33):21920-7. doi: 10.1074/jbc.M109.033688. Epub 2009 Jun 17.

20.

The role of clusterin in retinal development and free radical damage.

Kim JH, Kim JH, Yu YS, Min BH, Kim KW.

Br J Ophthalmol. 2007 Nov;91(11):1541-6. Epub 2007 May 2.

Supplemental Content

Support Center